Inventor
FATHEREE PAUL R
US128 patents
⚠️ This page may combine multiple inventors who share the name “FATHEREE PAUL R”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
THERAVANCE INC
34 patentsUS7879896B2Feb 1, 2011
Dual-acting imidazole antihypertensive agents
THERAVANCE INC53 citations98
US8013005B2Sep 6, 2011
Dual-acting antihypertensive agents
THERAVANCE INC42 citations96
US7655621B2Feb 2, 2010
Cross-linked glycopeptide-cephalosporin antibiotics
THERAVANCE INC26 citations96
US7649080B2Jan 19, 2010
Cross-linked glycopeptide-cephalosporin antibiotics
THERAVANCE INC24 citations96
US7601690B2Oct 13, 2009
Cross-linked glycopeptide-cephalosporin antibiotics
THERAVANCE INC25 citations96
US7375114B2May 20, 2008
Quinolinone-carboxamide compounds as 5-HT4 receptor agonists
THERAVANCE INC41 citations96
US7341993B2Mar 11, 2008
Cross-linked glycopeptide—cephalosporin antibiotics
THERAVANCE INC22 citations96
US7279458B2Oct 9, 2007
Cross-linked glycopeptide-cephalosporin antibiotics
THERAVANCE INC50 citations96
US6974797B2Dec 13, 2005
Cross-linked glycopeptide-cephalosporin antibiotics
THERAVANCE INC45 citations96
US6878686B2Apr 12, 2005
Cross-linked glycopeptide-cephalosporin antibiotics
THERAVANCE INC49 citations96
US7067481B2Jun 27, 2006
Cross-linked glycopeptide-cephalosporin antibiotics
THERAVANCE INC41 citations95
US8377964B2Feb 19, 2013
Benzimidazole-carboxamide compounds as 5-HT4 receptor agonists
THERAVANCE INC10 citations93
US8372984B2Feb 12, 2013
Dual-acting oxazole antihypertensive agents
THERAVANCE INC16 citations93
US7759363B2Jul 20, 2010
Benzimidazole-carboxamide compounds as 5-HT4, receptor agonists
THERAVANCE INC18 citations93
US7728127B2Jun 1, 2010
Cross-linked glycopeptide-cephalosporin antibiotics
THERAVANCE INC20 citations93
US7612037B2Nov 3, 2009
Cross-linked glycopeptide-cephalosporin antibiotics
THERAVANCE INC18 citations93
US7592355B2Sep 22, 2009
Quinolinone-carboxamide compounds as 5-HT, receptor agonists
THERAVANCE INC13 citations93
US7553962B2Jun 30, 2009
Cross-linked glycopeptide-cephalosporin antibiotics
THERAVANCE INC21 citations93
US7317022B2Jan 8, 2008
Benzoimidazolone-carboxamide compounds as 5-HT4 receptors agonists
THERAVANCE INC19 citations93
US6620781B2Sep 16, 2003
Glycopeptide carboxy-saccharide derivatives
THERAVANCE INC27 citations93
US7989484B2Aug 2, 2011
Dual-acting antihypertensive agents
THERAVANCE INC25 citations92
US7956054B2Jun 7, 2011
Dual-acting pyrazole antihypertensive agents
THERAVANCE INC21 citations92
US7863309B2Jan 4, 2011
Dual-acting antihypertensive agents
THERAVANCE INC27 citations92
US7834041B2Nov 16, 2010
Dual-acting antihypertensive agents
THERAVANCE INC29 citations92
US7763637B2Jul 27, 2010
Quinolinone-carboxamide compounds as 5-HT4, receptor agonists
THERAVANCE INC12 citations92
US7351704B2Apr 1, 2008
Indazole-carboxamide compounds as 5-HT4 receptor agonists
THERAVANCE INC25 citations92
US7332471B2Feb 19, 2008
Cross-linked glycopeptide-cephalosporin antibiotics
THERAVANCE INC21 citations92
US7183323B2Feb 27, 2007
Sodium channel modulators
THERAVANCE INC20 citations92
US7067482B2Jun 27, 2006
Cross-linked glycopeptide-cephalosporin antibiotics
THERAVANCE INC43 citations92
US6995138B2Feb 7, 2006
Cross-linked glycopeptide-cephalosporin antibiotics
THERAVANCE INC34 citations92
US6756400B2Jun 29, 2004
Sodium channel modulators
THERAVANCE INC36 citations92
US6646012B2Nov 11, 2003
Sodium channel modulators
THERAVANCE INC30 citations92
US7777077B2Aug 17, 2010
Dual-acting antihypertensive agents
THERAVANCE INC34 citations91
US7728006B2Jun 1, 2010
Quinolinone-carboxamide compounds as 5-HT4 receptor agonists
THERAVANCE INC11 citations84
THERAVANCE BIOPHARMA R&D IP LLC
12 patentsUS10196393B2Feb 5, 2019
JAK inhibitors containing a 4-membered heterocyclic amide
THERAVANCE BIOPHARMA R&D IP LLC24 citations98
US10550118B2Feb 4, 2020
JAK inhibitors containing a 4-membered heterocyclic amide
THERAVANCE BIOPHARMA R&D IP LLC13 citations94
US10526330B2Jan 7, 2020
JAK kinase inhibitor compounds for treatment of respiratory disease
THERAVANCE BIOPHARMA R&D IP LLC15 citations94
US10519153B2Dec 31, 2019
Fused imidazo-piperidine JAK inhibitors
THERAVANCE BIOPHARMA R&D IP LLC16 citations94
US10493077B2Dec 3, 2019
Fused imidazo-piperidine JAK inhibitor compound
THERAVANCE BIOPHARMA R&D IP LLC14 citations94
US10392386B2Aug 27, 2019
JAK inhibitors containing a 4-membered heterocyclic amide
THERAVANCE BIOPHARMA R&D IP LLC19 citations94
US10208040B2Feb 19, 2019
Fused imidazo-piperidine JAK inhibitors
THERAVANCE BIOPHARMA R&D IP LLC24 citations94
US10100049B2Oct 16, 2018
JAK kinase inhibitor compounds for treatment of respiratory disease
THERAVANCE BIOPHARMA R&D IP LLC28 citations93
US10028960B2Jul 24, 2018
Pyrimidine compounds as JAK kinase inhibitors
THERAVANCE BIOPHARMA R&D IP LLC18 citations93
US9725470B2Aug 8, 2017
Substituted naphthyridines as JAK kinase inhibitors
THERAVANCE BIOPHARMA R&D IP LLC27 citations93
US11254669B2Feb 22, 2022
Fused imidazo-piperidine JAK inhibitors
THERAVANCE BIOPHARMA R&D IP LLC3 citations84
US10954237B2Mar 23, 2021
JAK inhibitors containing a 4-membered heterocyclic amide
THERAVANCE BIOPHARMA R&D IP LLC2 citations84
CHOI SEOK-KI
1 patentALLEGRETTI PAUL
1 patentMARQUESS DANIEL
1 patentFATHEREE PAUL R
1 patentShowing the top 50 of 128 patents by PatentIndex Score.